Cover Image
市場調查報告書

睡眠助劑的全球市場分析

Global Market Study on Sleep Aids: Devices Product Type to Register a High Growth Rate During 2017 - 2025

出版商 Persistence Market Research 商品編碼 607618
出版日期 內容資訊 英文 207 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
睡眠助劑的全球市場分析 Global Market Study on Sleep Aids: Devices Product Type to Register a High Growth Rate During 2017 - 2025
出版日期: 2018年01月25日 內容資訊: 英文 207 Pages
簡介

本報告提供全球睡眠助劑的市場相關分析,產品概要和市場結構,主要的推動及阻礙市場要素,市場規模、佔有率、成長率的變化與預測 (過去5年、今後9年份),各產品種類、各症狀、各流通管道及各地區詳細趨勢,目前市場競爭狀態,主要企業簡介等調查。

第1章 摘要整理

第2章 市場概要

第3章 市場觀點

  • 宏觀經濟要素
  • 市場機會分析
  • 睡眠呼吸中止症的流行病學

第4章 北美的睡眠助劑市場:分析與預測

  • 簡介
  • 主要的法規
  • 地區市場動態
    • 推動及阻礙市場要素,市場趨勢
  • 市場規模的成果值:各國 (過去5年份)
  • 市場規模的預測值:各國 (今後9年份)
    • 美國
    • 加拿大
  • 市場規模的成果值、預測值:各產品種類 (總計14年份)
  • 市場規模的成果值、預測值:各症狀 (總計14年份)
  • 市場規模的成果值、預測值:各流通管道 (總計14年份)
  • 市場向心力分析:各國,各產品,各症狀,各流通管道
  • 主要打入市場企業
  • 市場優勢 (集中度地圖)

第5章 南美的睡眠助劑市場:分析與預測

  • 市場規模的成果值、預測值:各國 (總計14年份)
    • 巴西
    • 墨西哥
    • 其他

第6章 歐洲的睡眠助劑市場:分析與預測

  • 市場規模的成果值、預測值:各國 (總計14年份)
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 俄羅斯
    • 波蘭
    • 其他

第7章 亞太地區的睡眠助劑市場:分析與預測

  • 市場規模的成果值、預測值:各國 (總計14年份)
    • 中國
    • 印度
    • 日本
    • 澳洲、紐西蘭
    • 東南亞國協
    • 其他

第8章 中東、非洲的睡眠助劑市場:分析與預測

  • 市場規模的成果值、預測值:各國 (總計14年份)
    • 波灣合作理事會 (GCC) 各國
    • 南非
    • 其他

第9章 市場預測要素:相關性及影響度

第10章 市場預測的前提條件

第11章 競爭環境

  • 失眠症治療藥:各品牌市場佔有率
  • 市場集中度地圖:各市場分類
  • 市場參與企業的一覽
  • 企業簡介 (概要,財務分析,策略,近幾年趨勢)
    • ResMed Inc.
    • Koninklijke Philips N.V.
    • Merck & Co. Inc.
    • Drive DeVilbiss Healthcare LLC
    • GlaxoSmithKline Plc.
    • Fisher & Paykel Healthcare Limited
    • Sanofi SA
    • Pfizer Inc.

第12章 全球睡眠助劑市場分析與預測:各地區 (總計14年份)

  • 簡介/分析的要點
  • 市場規模的成果值:各地區 (過去5年份)
  • 市場規模的成果值:各預測 (今後9年份)
    • 北美
    • 南美
    • 歐洲
    • 亞太地區
    • 中東、非洲
  • 市場向心力分析:各地區

第13章 全球睡眠助劑市場分析與預測:各產品種類 (總計14年份)

  • 市場規模的成果值:各產品種類 (過去5年份)
  • 市場規模的成果值:各產品種類 (今後9年份)
    • 醫藥品
      • 失眠症治療藥
      • 猝睡症治療藥
    • 醫療設備
      • CPAP (持續式表面壓呼吸療法)設備
      • APAP (自動表面壓呼吸療法)設備
      • BiPAP (二相式表面壓呼吸療法)設備
    • 其他
      • 床墊、枕頭
      • 下巴帶
      • 護齒、鼻子用設備

第14章 全球睡眠助劑市場分析與預測:各症狀 (總計14年份)

  • 市場規模的成果值:各症狀 (過去5年份)
  • 市場規模的成果值:各症狀 (今後9年份)
    • 失眠症
    • 睡眠剝奪
    • 猝睡症
    • 睡眠呼吸中止症

第15章 全球睡眠助劑市場分析與預測:各流通管道 (總計14年份)

  • 市場規模的成果值:各流通管道 (過去5年份)
  • 市場規模的成果值:各流通管道 (今後9年份)
    • 院內藥局
    • 零售藥局
    • 電子商務
    • 藥妝店
    • 其他

第16章 全球市場的分析與預測 (過去5年、今後9年份)

  • 市場規模和年度成長率
  • 市場機會的絕對的規模

第17章 分析方法

目錄

Persistence Market Research uses a unique research methodology which is a strong blend of secondary and in-depth primary research. Extensive primary interviews with key market players, stakeholders, market observers and experts are carried out to collect necessary data and information pertaining to various segments and across key regions. The data crunching and statistical analysis so performed undergoes multiple layers of validation to garner appropriate market insights which could benefit business by impacting critical decisions. The exhaustive research methodology has been applied to thoroughly understand and study the market for sleep aids and the findings and insights have been skilfully crafted following a systematic structure in the new report on sleep aids market.

Research report on global sleep aids market offers support in every respect

The market research report on global sleep aids is a comprehensive market research study which focuses on the global scenario and provides actionable acumen on various factors which influence the market which is possible with the help of strong data and statistical analysis. It delivers an unbiased view of the market by including analysis on various market segments across the major geographies of North America, Latin America, Europe, Asia Pacific and Middle East and Africa (MEA). The global research report on sleep aids market has an in-depth weightage on statistics, figures, numbers and graphs which is based on a clear market definition. This will enable the reader to take informed decisions with the help of well-furnished insights. The upcoming trends and developments, new innovations in products and varying product portfolios, new acquisitions, end user analysis and much more actionable acumen give a 3600 view to the market ultimately providing the reader with necessary tools to devise strategies in order to establish firm grip in a particular region or in a particular segment in the global sleep aids market.

Market Segmentation

By Product

  • Drugs
    • Insomnia treatment drugs
    • Doxepin Hydrochloride
    • Eszopiclone
    • Ramelteon
    • Triazolam
    • Zaleplon
    • Quazepam
    • Others
  • Narcolepsy treatment drugs
    • Modafinil
    • Sodium oxybate
    • Armodafinil
    • Others
  • Devices
    • CPAP devices
    • BiPAP devices
    • APAP devices
    • Others
  • Mattresses & pillows
    • Chin Straps
    • Nasal devices and Mouthpieces

By Indication

  • Insomnia
  • Sleep Deprivation
  • Narcolepsy
  • Sleep Apnea
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • e commerce
  • Drug Stores
  • Others

By Region

  • North America
  • Europe
  • Latin America
  • Asia Pacific (APAC)
  • Middle East and Africa (MEA)

A detailed competitive analysis included in the research report:

The global sleep aids market research study covers competitive landscape that includes market shares, revenues, growth strategies applied, product portfolio analysis, distribution channels, expansion in several geographies, marketing strategies, SWOT analysis, pricing analysis, etc., of the various key players in the global sleep aids market. Such an intelligence framework can be used to gain competitive advantage in the long run, especially helpful for new entrants in the sleep aids market.

Delivering value - below facts support the statement:

  • In-depth market analysis, with scrutiny across important geographies
  • Weighted market segmentation to have a complete market understanding
  • Historical data, current statistics and a projected view of the market (forecasts) over a period of five years available in a well-structured format
  • Competitive landscape covering analyses on key players
  • Unbiased view of the global market drawing a realistic outline of data projections
  • Strong accurate research from a strategic standpoint to gain strategic advantage
  • Weighted analysis which covers each and every aspect of the global sleep aids market

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy
  • 2.3. Sleep Aids Market Overview

3. Market View Point

  • 3.1. Macro-Economic Factors
  • 3.2. Opportunity Analysis
  • 3.3. Epidemiology of sleep apnea

4. North America Sleep Aids Market Analysis 2012-2016 and Forecast 2017-2025

  • 4.1. Introduction
  • 4.2. Key Regulations
  • 4.3. Regional Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Trends
  • 4.4. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
    • 4.4.1. U.S.
    • 4.4.2. Canada
  • 4.5. Market Size (US$ Mn) Forecast By Country, 2017-2025
    • 4.5.1. U.S.
    • 4.5.2. Canada
  • 4.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
    • 4.6.1. Drugs
      • 4.6.1.1. Insomnia treatment drugs
        • 4.6.1.1.1. Doxepin Hydrochloride
        • 4.6.1.1.2. Eszopiclone
        • 4.6.1.1.3. Ramelteon
        • 4.6.1.1.4. Triazolam
        • 4.6.1.1.5. Zaleplon
        • 4.6.1.1.6. Quazepam
        • 4.6.1.1.7. Others
      • 4.6.1.2. Narcolepsy treatment drugs
        • 4.6.1.2.1. Modafinil
        • 4.6.1.2.2. Sodium oxybate
        • 4.6.1.2.3. Armodafinil
        • 4.6.1.2.4. Others
    • 4.6.2. Devices
      • 4.6.2.1. CPAP devices
      • 4.6.2.2. BiPAP devices
      • 4.6.2.3. APAP devices
    • 4.6.3. Others
      • 4.6.3.1. Mattresses and Pillows
      • 4.6.3.2. Chin Straps
      • 4.6.3.3. Mouth Pieces and Nasal Devices
  • 4.7. Market Size (US$ Mn) Forecast By Product Type, 2017-2025
    • 4.7.1. Drugs
      • 4.7.1.1. Insomnia treatment drugs
        • 4.7.1.1.1. Doxepin Hydrochloride
        • 4.7.1.1.2. Eszopiclone
        • 4.7.1.1.3. Ramelteon
        • 4.7.1.1.4. Triazolam
        • 4.7.1.1.5. Zaleplon
        • 4.7.1.1.6. Quazepam
        • 4.7.1.1.7. Others
      • 4.7.1.2. Narcolepsy treatment drugs
        • 4.7.1.2.1. Modafinil
        • 4.7.1.2.2. Sodium oxybate
        • 4.7.1.2.3. Armodafinil
        • 4.7.1.2.4. Others
    • 4.7.2. Devices
      • 4.7.2.1. CPAP devices
      • 4.7.2.2. BiPAP devices
      • 4.7.2.3. APAP devices
    • 4.7.3. Others
      • 4.7.3.1. Mattresses and Pillows
      • 4.7.3.2. Chin Straps
      • 4.7.3.3. Mouth Pieces and Nasal Devices
  • 4.8. Historical Market Size (US$ Mn) Analysis By Indication, 2012-2016
    • 4.8.1. Insomnia
    • 4.8.2. Sleep Deprivation
    • 4.8.3. Narcolepsy
    • 4.8.4. Sleep Apnea
    • 4.8.5. Others
  • 4.9. Market Size (US$ Mn) Forecast By Indication, 2017-2025
    • 4.9.1. Insomnia
    • 4.9.2. Sleep Deprivation
    • 4.9.3. Narcolepsy
    • 4.9.4. Sleep Apnea
    • 4.9.5. Others
  • 4.10.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
    • 4.10.1. Hospital Pharmacies
    • 4.10.2. Retail Pharmacies
    • 4.10.3. e-commerce
    • 4.10.4. Drug Stores
    • 4.10.5. Others
  • 4.11.Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2025
    • 4.11.1. Hospital Pharmacies
    • 4.11.2. Retail Pharmacies
    • 4.11.3. e-commerce
    • 4.11.4. Drug Stores
    • 4.11.5. Others
  • 4.12.Market Attractiveness Analysis
    • 4.12.1. By Country
    • 4.12.2. By Product type
    • 4.12.3. By Indication
    • 4.12.4. By Distribution Channel
  • 4.13.Key Representative Market Participants
  • 4.14.Key Participants Market Presence (Intensity Map)

5. Latin America Sleep Aids Market Analysis 2012-2016 and Forecast 2017-2025

  • 5.1. Introduction
  • 5.2. Key Regulations
  • 5.3. Regional Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Trends
  • 5.4. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
    • 5.4.1. Brazil
    • 5.4.2. Mexico
    • 5.4.3. Rest of Latin America
  • 5.5. Market Size (US$ Mn) Forecast By Country, 2017-2025
    • 5.5.1. Brazil
    • 5.5.2. Mexico
    • 5.5.3. Rest of Latin America
  • 5.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
    • 5.6.1. Drugs
      • 5.6.1.1. Insomnia treatment drugs
        • 5.6.1.1.1. Doxepin Hydrochloride
        • 5.6.1.1.2. Eszopiclone
        • 5.6.1.1.3. Ramelteon
        • 5.6.1.1.4. Triazolam
        • 5.6.1.1.5. Zaleplon
        • 5.6.1.1.6. Quazepam
        • 5.6.1.1.7. Others
      • 5.6.1.2. Narcolepsy treatment drugs
        • 5.6.1.2.1. Modafinil
        • 5.6.1.2.2. Sodium oxybate
        • 5.6.1.2.3. Armodafinil
        • 5.6.1.2.4. Others
    • 5.6.2. Devices
      • 5.6.2.1. CPAP devices
      • 5.6.2.2. BiPAP devices
      • 5.6.2.3. APAP devices
    • 5.6.3. Others
      • 5.6.3.1. Mattresses and Pillows
      • 5.6.3.2. Chin Straps
      • 5.6.3.3. Mouth Pieces and Nasal Devices
  • 5.7. Market Size (US$ Mn) Forecast By Product Type, 2017-2025
    • 5.7.1. Drugs
      • 5.7.1.1. Insomnia treatment drugs
        • 5.7.1.1.1. Doxepin Hydrochloride
        • 5.7.1.1.2. Eszopiclone
        • 5.7.1.1.3. Ramelteon
        • 5.7.1.1.4. Triazolam
        • 5.7.1.1.5. Zaleplon
        • 5.7.1.1.6. Quazepam
        • 5.7.1.1.7. Others
      • 5.7.1.2. Narcolepsy treatment drugs
        • 5.7.1.2.1. Modafinil
        • 5.7.1.2.2. Sodium oxybate
        • 5.7.1.2.3. Armodafinil
        • 5.7.1.2.4. Others
    • 5.7.2. Devices
      • 5.7.2.1. CPAP devices
      • 5.7.2.2. BiPAP devices
      • 5.7.2.3. APAP devices
    • 5.7.3. Others
      • 5.7.3.1. Mattresses and Pillows
      • 5.7.3.2. Chin Straps
      • 5.7.3.3. Mouth Pieces and Nasal Devices
  • 5.8. Historical Market Size (US$ Mn) Analysis By Indication, 2012-2016
    • 5.8.1. Insomnia
    • 5.8.2. Sleep Deprivation
    • 5.8.3. Narcolepsy
    • 5.8.4. Sleep Apnea
    • 5.8.5. Others
  • 5.9. Market Size (US$ Mn) Forecast By Indication, 2017-2025
    • 5.9.1. Insomnia
    • 5.9.2. Sleep Deprivation
    • 5.9.3. Narcolepsy
    • 5.9.4. Sleep Apnea
    • 5.9.5. Others
  • 5.10.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
    • 5.10.1. Hospital Pharmacies
    • 5.10.2. Retail Pharmacies
    • 5.10.3. e-commerce
    • 5.10.4. Drug Stores
    • 5.10.5. Others
  • 5.11.Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2025
    • 5.11.1. Hospital Pharmacies
    • 5.11.2. Retail Pharmacies
    • 5.11.3. e-commerce
    • 5.11.4. Drug Stores
    • 5.11.5. Others
  • 5.12.Market Attractiveness Analysis
    • 5.12.1. By Country
    • 5.12.2. By Product type
    • 5.12.3. By Indication
    • 5.12.4. By Distribution Channel
  • 5.13.Key Representative Market Participants
  • 5.14.Key Participants Market Presence (Intensity Map)

6. Europe Sleep Aids Market Analysis 2012-2016 and Forecast 2017-2025

  • 6.1. Introduction
  • 6.2. Key Regulations
  • 6.3. Regional Market Dynamics
    • 6.3.1. Drivers
    • 6.3.2. Restraints
    • 6.3.3. Trends
  • 6.4. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Spain
    • 6.4.5. Italy
    • 6.4.6. Russia
    • 6.4.7. Poland
    • 6.4.8. Rest of Europe
  • 6.5. Market Size (US$ Mn) Forecast By Country, 2017-2025
    • 6.5.1. Germany
    • 6.5.2. France
    • 6.5.3. U.K.
    • 6.5.4. Spain
    • 6.5.5. Italy
    • 6.5.6. Russia
    • 6.5.7. Poland
    • 6.5.8. Rest of Europe
  • 6.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
    • 6.6.1. Drugs
      • 6.6.1.1. Insomnia treatment drugs
        • 6.6.1.1.1. Doxepin Hydrochloride
        • 6.6.1.1.2. Eszopiclone
        • 6.6.1.1.3. Ramelteon
        • 6.6.1.1.4. Triazolam
        • 6.6.1.1.5. Zaleplon
        • 6.6.1.1.6. Quazepam
        • 6.6.1.1.7. Others
      • 6.6.1.2. Narcolepsy treatment drugs
        • 6.6.1.2.1. Modafinil
        • 6.6.1.2.2. Sodium oxybate
        • 6.6.1.2.3. Armodafinil
        • 6.6.1.2.4. Others
    • 6.6.2. Devices
      • 6.6.2.1. CPAP devices
      • 6.6.2.2. BiPAP devices
      • 6.6.2.3. APAP devices
    • 6.6.3. Others
      • 6.6.3.1. Mattresses and Pillows
      • 6.6.3.2. Chin Straps
      • 6.6.3.3. Mouth Pieces and Nasal Devices
  • 6.7. Market Size (US$ Mn) Forecast By Product Type, 2017-2025
    • 6.7.1. Drugs
      • 6.7.1.1. Insomnia treatment drugs
        • 6.7.1.1.1. Doxepin Hydrochloride
        • 6.7.1.1.2. Eszopiclone
        • 6.7.1.1.3. Ramelteon
        • 6.7.1.1.4. Triazolam
        • 6.7.1.1.5. Zaleplon
        • 6.7.1.1.6. Quazepam
        • 6.7.1.1.7. Others
      • 6.7.1.2. Narcolepsy treatment drugs
        • 6.7.1.2.1. Modafinil
        • 6.7.1.2.2. Sodium oxybate
        • 6.7.1.2.3. Armodafinil
        • 6.7.1.2.4. Others
    • 6.7.2. Devices
      • 6.7.2.1. CPAP devices
      • 6.7.2.2. BiPAP devices
      • 6.7.2.3. APAP devices
    • 6.7.3. Others
      • 6.7.3.1. Mattresses and Pillows
      • 6.7.3.2. Chin Straps
      • 6.7.3.3. Mouth Pieces and Nasal Devices
  • 6.8. Historical Market Size (US$ Mn) Analysis By Indication, 2012-2016
    • 6.8.1. Insomnia
    • 6.8.2. Sleep Deprivation
    • 6.8.3. Narcolepsy
    • 6.8.4. Sleep Apnea
    • 6.8.5. Others
  • 6.9. Market Size (US$ Mn) Forecast By Indication, 2017-2025
    • 6.9.1. Insomnia
    • 6.9.2. Sleep Deprivation
    • 6.9.3. Narcolepsy
    • 6.9.4. Sleep Apnea
    • 6.9.5. Others
  • 6.10.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
    • 6.10.1. Hospital Pharmacies
    • 6.10.2. Retail Pharmacies
    • 6.10.3. e-commerce
    • 6.10.4. Drug Stores
    • 6.10.5. Others
  • 6.11.Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2025
    • 6.11.1. Hospital Pharmacies
    • 6.11.2. Retail Pharmacies
    • 6.11.3. e-commerce
    • 6.11.4. Drug Stores
    • 6.11.5. Others
  • 6.12.Market Attractiveness Analysis
    • 6.12.1. By Country
    • 6.12.2. By Product type
    • 6.12.3. By Indication
    • 6.12.4. By Distribution Channel
  • 6.13.Key Representative Market Participants
  • 6.14.Key Participants Market Presence (Intensity Map)

7. Asia Pacific Sleep Aids Market Analysis 2012-2016 and Forecast 2017-2025

  • 7.1. Introduction
  • 7.2. Key Regulations
  • 7.3. Regional Market Dynamics
    • 7.3.1. Drivers
    • 7.3.2. Restraints
    • 7.3.3. Trends
  • 7.4. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
    • 7.4.1. China
    • 7.4.2. India
    • 7.4.3. Japan
    • 7.4.4. Australia and New Zealand
    • 7.4.5. ASEAN
    • 7.4.6. Rest of Asia Pacific
  • 7.5. Market Size (US$ Mn) Forecast By Country, 2017-2025
    • 7.5.1. China
    • 7.5.2. India
    • 7.5.3. Japan
    • 7.5.4. Australia and New Zealand
    • 7.5.5. ASEAN
    • 7.5.6. Rest of Asia Pacific
  • 7.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
    • 7.6.1. Drugs
      • 7.6.1.1. Insomnia treatment drugs
        • 7.6.1.1.1. Doxepin Hydrochloride
        • 7.6.1.1.2. Eszopiclone
        • 7.6.1.1.3. Ramelteon
        • 7.6.1.1.4. Triazolam
        • 7.6.1.1.5. Zaleplon
        • 7.6.1.1.6. Quazepam
        • 7.6.1.1.7. Others
      • 7.6.1.2. Narcolepsy treatment drugs
        • 7.6.1.2.1. Modafinil
        • 7.6.1.2.2. Sodium oxybate
        • 7.6.1.2.3. Armodafinil
        • 7.6.1.2.4. Others
    • 7.6.2. Devices
      • 7.6.2.1. CPAP devices
      • 7.6.2.2. BiPAP devices
      • 7.6.2.3. APAP devices
    • 7.6.3. Others
      • 7.6.3.1. Mattresses and Pillows
      • 7.6.3.2. Chin Straps
      • 7.6.3.3. Mouth Pieces and Nasal Devices
  • 7.7. Market Size (US$ Mn) Forecast By Product Type, 2017-2025
    • 7.7.1. Drugs
      • 7.7.1.1. Insomnia treatment drugs
        • 7.7.1.1.1. Doxepin Hydrochloride
        • 7.7.1.1.2. Eszopiclone
        • 7.7.1.1.3. Ramelteon
        • 7.7.1.1.4. Triazolam
        • 7.7.1.1.5. Zaleplon
        • 7.7.1.1.6. Quazepam
        • 7.7.1.1.7. Others
      • 7.7.1.2. Narcolepsy treatment drugs
        • 7.7.1.2.1. Modafinil
        • 7.7.1.2.2. Sodium oxybate
        • 7.7.1.2.3. Armodafinil
        • 7.7.1.2.4. Others
    • 7.7.2. Devices
      • 7.7.2.1. CPAP devices
      • 7.7.2.2. BiPAP devices
      • 7.7.2.3. APAP devices
    • 7.7.3. Others
      • 7.7.3.1. Mattresses and Pillows
      • 7.7.3.2. Chin Straps
      • 7.7.3.3. Mouth Pieces and Nasal Devices
  • 7.8. Historical Market Size (US$ Mn) Analysis By Indication, 2012-2016
    • 7.8.1. Insomnia
    • 7.8.2. Sleep Deprivation
    • 7.8.3. Narcolepsy
    • 7.8.4. Sleep Apnea
    • 7.8.5. Others
  • 7.9. Market Size (US$ Mn) Forecast By Indication, 2017-2025
    • 7.9.1. Insomnia
    • 7.9.2. Sleep Deprivation
    • 7.9.3. Narcolepsy
    • 7.9.4. Sleep Apnea
    • 7.9.5. Others
  • 7.10.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
    • 7.10.1. Hospital Pharmacies
    • 7.10.2. Retail Pharmacies
    • 7.10.3. e-commerce
    • 7.10.4. Drug Stores
    • 7.10.5. Others
  • 7.11.Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2025
    • 7.11.1. Hospital Pharmacies
    • 7.11.2. Retail Pharmacies
    • 7.11.3. e-commerce
    • 7.11.4. Drug Stores
    • 7.11.5. Others
  • 7.12.Market Attractiveness Analysis
    • 7.12.1. By Country
    • 7.12.2. By Product type
    • 7.12.3. By Indication
    • 7.12.4. By Distribution Channel
  • 7.13.Key Representative Market Participants
  • 7.14.Key Participants Market Presence (Intensity Map)

8. MEA Sleep Aids Market Analysis 2012-2016 and Forecast 2017-2025

  • 8.1. Introduction
  • 8.2. Key Regulations
  • 8.3. Regional Market Dynamics
    • 8.3.1. Drivers
    • 8.3.2. Restraints
    • 8.3.3. Trends
  • 8.4. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
    • 8.4.1. GCC Countries
    • 8.4.2. South Africa
    • 8.4.3. Rest of MEA
  • 8.5. Market Size (US$ Mn) Forecast By Country, , 2017-2025
    • 8.5.1. GCC Countries
    • 8.5.2. South Africa
    • 8.5.3. Rest of MEA
  • 8.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
    • 8.6.1. Drugs
      • 8.6.1.1. Insomnia treatment drugs
        • 8.6.1.1.1. Doxepin Hydrochloride
        • 8.6.1.1.2. Eszopiclone
        • 8.6.1.1.3. Ramelteon
        • 8.6.1.1.4. Triazolam
        • 8.6.1.1.5. Zaleplon
        • 8.6.1.1.6. Quazepam
        • 8.6.1.1.7. Others
      • 8.6.1.2. Narcolepsy treatment drugs
        • 8.6.1.2.1. Modafinil
        • 8.6.1.2.2. Sodium oxybate
        • 8.6.1.2.3. Armodafinil
        • 8.6.1.2.4. Others
    • 8.6.2. Devices
      • 8.6.2.1. CPAP devices
      • 8.6.2.2. BiPAP devices
      • 8.6.2.3. APAP devices
    • 8.6.3. Others
      • 8.6.3.1. Mattresses and Pillows
      • 8.6.3.2. Chin Straps
      • 8.6.3.3. Mouth Pieces and Nasal Devices
  • 8.7. Market Size (US$ Mn) Forecast By Product Type, 2017-2025
    • 8.7.1. Drugs
      • 8.7.1.1. Insomnia treatment drugs
        • 8.7.1.1.1. Doxepin Hydrochloride
        • 8.7.1.1.2. Eszopiclone
        • 8.7.1.1.3. Ramelteon
        • 8.7.1.1.4. Triazolam
        • 8.7.1.1.5. Zaleplon
        • 8.7.1.1.6. Quazepam
        • 8.7.1.1.7. Others
      • 8.7.1.2. Narcolepsy treatment drugs
        • 8.7.1.2.1. Modafinil
        • 8.7.1.2.2. Sodium oxybate
        • 8.7.1.2.3. Armodafinil
        • 8.7.1.2.4. Others
    • 8.7.2. Devices
      • 8.7.2.1. CPAP devices
      • 8.7.2.2. BiPAP devices
      • 8.7.2.3. APAP devices
    • 8.7.3. Others
      • 8.7.3.1. Mattresses and Pillows
      • 8.7.3.2. Chin Straps
      • 8.7.3.3. Mouth Pieces and Nasal Devices
  • 8.8. Historical Market Size (US$ Mn) Analysis By Indication, 2012-2016
    • 8.8.1. Insomnia
    • 8.8.2. Sleep Deprivation
    • 8.8.3. Narcolepsy
    • 8.8.4. Sleep Apnea
    • 8.8.5. Others
  • 8.9. Market Size (US$ Mn) Forecast By Indication, 2017-2025
    • 8.9.1. Insomnia
    • 8.9.2. Sleep Deprivation
    • 8.9.3. Narcolepsy
    • 8.9.4. Sleep Apnea
    • 8.9.5. Others
  • 8.10.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
    • 8.10.1. Hospital Pharmacies
    • 8.10.2. Retail Pharmacies
    • 8.10.3. e-commerce
    • 8.10.4. Drug Stores
    • 8.10.5. Others
  • 8.11.Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2025
    • 8.11.1. Hospital Pharmacies
    • 8.11.2. Retail Pharmacies
    • 8.11.3. e-commerce
    • 8.11.4. Drug Stores
    • 8.11.5. Others
  • 8.12.Market Attractiveness Analysis
    • 8.12.1. By Country
    • 8.12.2. By Product type
    • 8.12.3. By Indication
    • 8.12.4. By Distribution Channel
  • 8.13.Key Representative Market Participants
  • 8.14.Key Participants Market Presence (Intensity Map)

9. Forecast Factors: Relevance and Impact

10. Forecast Assumptions

11. Competition Landscape

  • 11.1.Insomnia Brand Share Analysis
  • 11.2.Competition Intensity Mapping By Market Taxonomy
  • 11.3.Competition Dashboard
  • 11.4.Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.4.1. ResMed Inc.
    • 11.4.2. Koninklijke Philips N.V.
    • 11.4.3. Merck & Co. Inc.
    • 11.4.4. Drive DeVilbiss Healthcare LLC
    • 11.4.5. GlaxoSmithKline Plc.
    • 11.4.6. Fisher & Paykel Healthcare Limited
    • 11.4.7. Sanofi SA
    • 11.4.8. Pfizer Inc.

12. Global Sleep Aids Market Analysis 2012-2016 and Forecast 2017-2025, By Region

  • 12.1.Introduction / Key Findings
  • 12.2.Historical Market Size (US$ Mn) Analysis By Region, 2012-2016
    • 12.2.1. North America
    • 12.2.2. Latin America
    • 12.2.3. Europe
    • 12.2.4. Asia Pacific
    • 12.2.5. MEA
  • 12.3.Market Size (US$ Mn) Forecast By Region, 2017-2025
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. Asia Pacific
    • 12.3.5. MEA
  • 12.4.Market Attractiveness Analysis By Region

13. Global Sleep Aids Market Analysis 2012-2016 and Forecast 2017-2025, By Product Type

  • 13.1.Introduction
  • 13.2.Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
    • 13.2.1. Drugs
      • 13.2.1.1. Insomnia treatment drugs
        • 13.2.1.1.1. Doxepin Hydrochloride
        • 13.2.1.1.2. Eszopiclone
        • 13.2.1.1.3. Ramelteon
        • 13.2.1.1.4. Triazolam
        • 13.2.1.1.5. Zaleplon
        • 13.2.1.1.6. Quazepam
        • 13.2.1.1.7. Others
      • 13.2.1.2. Narcolepsy treatment drugs
        • 13.2.1.2.1. Modafinil
        • 13.2.1.2.2. Sodium oxybate
        • 13.2.1.2.3. Armodafinil
        • 13.2.1.2.4. Others
    • 13.2.2. Devices
      • 13.2.2.1. CPAP devices
      • 13.2.2.2. BiPAP devices
      • 13.2.2.3. APAP devices
    • 13.2.3. Others
      • 13.2.3.1. Mattresses and Pillows
      • 13.2.3.2. Chin Straps
      • 13.2.3.3. Mouth Pieces and Nasal Devices
  • 13.3.Market Size (US$ Mn) Forecast By Product Type, 2017-2025
    • 13.3.1. Drugs
      • 13.3.1.1. Insomnia treatment drugs
        • 13.3.1.1.1. Doxepin Hydrochloride
        • 13.3.1.1.2. Eszopiclone
        • 13.3.1.1.3. Ramelteon
        • 13.3.1.1.4. Triazolam
        • 13.3.1.1.5. Zaleplon
        • 13.3.1.1.6. Quazepam
        • 13.3.1.1.7. Others
      • 13.3.1.2. Narcolepsy treatment drugs
        • 13.3.1.2.1. Modafinil
        • 13.3.1.2.2. Sodium oxybate
        • 13.3.1.2.3. Armodafinil
        • 13.3.1.2.4. Others
    • 13.3.2. Devices
      • 13.3.2.1. CPAP devices
      • 13.3.2.2. BiPAP devices
      • 13.3.2.3. APAP devices
    • 13.3.3. Others
      • 13.3.3.1. Mattresses and Pillows
      • 13.3.3.2. Chin Straps
      • 13.3.3.3. Mouth Pieces and Nasal Devices
  • 13.4.Key Trends / Developments
  • 13.5.Market Attractiveness Analysis By Product Type

14. Global Sleep Aids Market Analysis 2012-2016 and Forecast 2017-2025, By Indication

  • 14.1.Introduction
  • 14.2.Historical Market Size (US$ Mn) Analysis By Indication, 2012-2016
    • 14.2.1. Insomnia
    • 14.2.2. Sleep Deprivation
    • 14.2.3. Narcolepsy
    • 14.2.4. Sleep Apnea
    • 14.2.5. Others
  • 14.3.Market Size (US$ Mn) Forecast By Indication, 2017-2025
    • 14.3.1. Insomnia
    • 14.3.2. Sleep Deprivation
    • 14.3.3. Narcolepsy
    • 14.3.4. Sleep Apnea
    • 14.3.5. Others
  • 14.4.Key Trends / Developments
  • 14.5.Market Attractiveness Analysis By Indication

15. Global Sleep Aids Market Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel

  • 15.1.Introduction
  • 15.2.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
    • 15.2.1. Hospital Pharmacies
    • 15.2.2. Retail Pharmacies
    • 15.2.3. e-commerce
    • 15.2.4. Drug Stores
    • 15.2.5. Others
  • 15.3.Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2025
    • 15.3.1. Hospital Pharmacies
    • 15.3.2. Retail Pharmacies
    • 15.3.3. e-commerce
    • 15.3.4. Drug Stores
    • 15.3.5. Others
  • 15.4.Key Trends / Developments
  • 15.5.Market Attractiveness Analysis By Distribution Channel

16. Global Market Analysis 2012-2016 and Forecast 2017-2025

  • 16.1.Market Size and Y-o-Y Growth
  • 16.2.Absolute $ Opportunity

17. Research Methodology

List of Tables

  • Table 1: North America Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
  • Table 2: North America Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
  • Table 3: North America Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
  • Table 4: North America Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Indication
  • Table 5: North America Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
  • Table 6: Latin America Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
  • Table 7: Latin America Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
  • Table 8: Latin America Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
  • Table 9: Latin America Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Indication
  • Table 10: Latin America Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
  • Table 11: Europe Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
  • Table 12: Europe Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
  • Table 13: Europe Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
  • Table 14: Europe Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Indication
  • Table 15: Europe Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
  • Table 16: Asia Pacific Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
  • Table 17: Asia Pacific Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
  • Table 18: Asia Pacific Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
  • Table 19: Asia Pacific Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Indication
  • Table 20: Asia Pacific Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
  • Table 21: MEA Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
  • Table 22: MEA Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
  • Table 23: MEA Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
  • Table 23: Global Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
  • Table 24: MEA Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Indication
  • Table 25: MEA Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
  • Table 26: Global Sleep Aids Market Size (US$ Mn) 2012-2016 and Forecast 2017-2025 By Region
  • Table 27: Global Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
  • Table 28: MEA Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Indication
  • Table 29: Global Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel

List of Figures

  • Figure 01: Sleep Aids Market Value Share By Product Type (2017)
  • Figure 02: Sleep Aids Market Value Share By Indication (2017)
  • Figure 03: Sleep Aids Market Value Share By Distribution Channel (2017)
  • Figure 04: Sleep Aids Market Value Share By Region (2017)
  • Figure 05: Global Sleep Aids Market Value (US$ Mn) Forecast 2017 and 2025
  • Figure 06: Sleep Aids Market Split By Product Type (2017)
  • Figure 07: Sleep Aids Market Split By Indication (2017)
  • Figure 08: Sleep Aids Market Split By Distribution Channel (2017)
  • Figure 09: Sleep Aids Market Split By Country (2017)
  • Figure 10: Percentage of adults aged 20 and over using prescription sleep aids, by age: United States, 2005-2010
  • Figure 11: North America Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 12: North America Sleep Aids Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 13: U.S. Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 14: U.S. Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 15: Canada Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 16: Canada Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 17: Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016, By Drugs
  • Figure 18: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By Drugs
  • Figure 19: Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016, By Devices
  • Figure 20: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By Devices
  • Figure 21: Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016, By Others
  • Figure 22: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By Others
  • Figure 23: North America Sleep Aids Market Attractiveness Analysis, By Product Type
  • Figure 24: North America Sleep Aids Market Attractiveness Analysis, By Indication
  • Figure 25: North America Sleep Aids Market Attractiveness Analysis, By Distribution Channel
  • Figure 26: North America Sleep Aids Market Attractiveness Analysis, By Country
  • Figure 27: Sleep Aids Market Split By Product Type (2017)
  • Figure 28: Sleep Aids Market Split By Indication (2017)
  • Figure 29: Sleep Aids Market Split By Distribution Channel (2017)
  • Figure 30: Sleep Aids Market Split By Country (2017)
  • Figure 31: Latin America Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 32: Latin America Sleep Aids Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 33: Brazil Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 34: Brazil Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 35: Mexico Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 36: Mexico Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 37: Rest of Latin America Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 38: Rest of Latin America Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 39: Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016, By Drugs
  • Figure 40: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By Drugs
  • Figure 41: Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016, By Devices
  • Figure 42: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By Devices
  • Figure 43: Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016, By Others
  • Figure 44: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By Others
  • Figure 45: Latin America Sleep Aids Market Attractiveness Analysis, By Product Type
  • Figure 46: Latin America Sleep Aids Market Attractiveness Analysis, By Indication
  • Figure 47: Latin America Sleep Aids Market Attractiveness Analysis, By Distribution Channel
  • Figure 48: Latin America Sleep Aids Market Attractiveness Analysis, By Country
  • Figure 49: Sleep Aids Market Split By Product Type (2017)
  • Figure 50: Sleep Aids Market Split By Indication (2017)
  • Figure 51: Sleep Aids Market Split By Distribution Channel (2017)
  • Figure 52: Sleep Aids Market Split By Country (2017)
  • Figure 53: Europe Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 54: Europe Sleep Aids Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 55: Germany Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 56: Germany Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 57: UK Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 58: UK Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 59: France Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 60: France Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 61: Italy Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 62: Italy Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 63: Spain Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 64: Spain Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 65: Russia Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 66: Russia Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 67: Poland Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 68: Poland Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 69: Rest of Europe Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 70: Rest of Europe Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 71: Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016, By Drugs
  • Figure 72: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By Drugs
  • Figure 73: Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016, By Devices
  • Figure 74: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By Devices
  • Figure 75: Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016, By Others
  • Figure 76: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By Others
  • Figure 77: Europe Sleep Aids Market Attractiveness Analysis, By Product Type
  • Figure 78: Europe Sleep Aids Market Attractiveness Analysis, By Indication
  • Figure 79: Europe Sleep Aids Market Attractiveness Analysis, By Distribution Channel
  • Figure 80: Europe Sleep Aids Market Attractiveness Analysis, By Country
  • Figure 81: Sleep Aids Market Split By Product Type (2017)
  • Figure 82: Sleep Aids Market Split By Indication (2017)
  • Figure 83: Sleep Aids Market Split By Distribution Channel (2017)
  • Figure 84: Sleep Aids Market Split By Country (2017)
  • Figure 85: Asia Pacific Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 86: Asia Pacific Sleep Aids Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 87: Japan Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 88: Japan Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 89: India Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 90: India Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 91: China Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 92: China Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 93: Australia And New Zealand Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 94: Australia And New Zealand Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 95: ASEAN Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 96: ASEAN Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 97: Rest of Asia Pacific Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 98: Rest of Asia Pacific Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 99: Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016, By Drugs
  • Figure 100: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By Drugs
  • Figure 101: Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016, By Devices
  • Figure 102: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By Devices
  • Figure 103: Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016, By Others
  • Figure 104: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By Others
  • Figure 105: Asia Pacific Sleep Aids Market Attractiveness Analysis, By Product Type
  • Figure 106: Asia Pacific Sleep Aids Market Attractiveness Analysis, By Indication
  • Figure 107: Asia Pacific Sleep Aids Market Attractiveness Analysis, By Distribution Channel
  • Figure 108: Asia Pacific Sleep Aids Market Attractiveness Analysis, By Country
  • Figure 109: Sleep Aids Market Split By Product Type (2017)
  • Figure 110: Sleep Aids Market Split By Indication (2017)
  • Figure 111: Sleep Aids Market Split By Distribution Channel (2017)
  • Figure 112 Sleep Aids Market Split By Country (2017)
  • Figure 113: MEA Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 114: MEA Sleep Aids Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 115: GCC Countries Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 116: GCC Countries Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 117: South Africa Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 118: South Africa Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 119: Rest of MEA Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 120: Rest of MEA Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 121: Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016, By Drugs
  • Figure 122: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By Drugs
  • Figure 123: Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016, By Devices
  • Figure 124: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By Devices
  • Figure 125: Sleep Aids Market Size (US$ Mn) Analysis, 2012-2016, By Others
  • Figure 126: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By Others
  • Figure 127: MEA Sleep Aids Market Attractiveness Analysis, By Product Type
  • Figure 128: MEA Sleep Aids Market Attractiveness Analysis, By Indication
  • Figure 129: MEA Sleep Aids Market Attractiveness Analysis, By Distribution Channel
  • Figure 130: MEA Sleep Aids Market Attractiveness Analysis, By Country
  • Figure 131: Global Sleep Aids Market Share Analysis (%) By Region, 2017 & 2025
  • Figure 132: Global Sleep Aids Market Y-o-Y Growth (%) By Region, 2016-2025
  • Figure 133: Global Sleep Aids Market Attractiveness Analysis By Region, 2017-2025
  • Figure 134: Global Sleep Aids Market Share Analysis (%) By Product Type, 2017 & 2025
  • Figure 135: Global Sleep Aids Market Y-o-Y Growth (%) By Product Type, 2016-2025
  • Figure 136: Global Sleep Aids Market Attractiveness Analysis By Product Type , 2017-2025
  • Figure 137: Global Sleep Aids Market Share Analysis (%) By Indication, 2017 & 2025
  • Figure 138: Global Sleep Aids Market Y-o-Y Growth (%) By Indication, 2016-2025
  • Figure 139: Global Sleep Aids Market Attractiveness Analysis By Indication, 2017-2025
  • Figure 140: Global Sleep Aids Market Share Analysis (%) By Distribution Channel, 2017 & 2025
  • Figure 141: Global Sleep Aids Market Y-o-Y Growth (%) By Distribution Channel, 2016-2025
  • Figure 142: Global Sleep Aids Market Attractiveness Analysis By Distribution Channel, 2017-2025
  • Figure 143: Global Sleep Aids Market Value Analysis and Forecast, 2016-2025 (US$ Mn)
Back to Top